Total Payments
$2,736
2024 Payments
$22.34
Companies
15
Transactions
93
Payment Breakdown by Category
Food & Beverage$2,725 (99.6%)
Education$11.02 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,725 | 91 | 99.6% |
| Education | $11.02 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $698.96 | 21 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $589.26 | 25 | $0 (2021) |
| Novo Nordisk Inc | $286.54 | 7 | $0 (2018) |
| AbbVie Inc. | $260.96 | 7 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $194.93 | 10 | $0 (2018) |
| Medtronic, Inc. | $132.93 | 3 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $124.95 | 1 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $122.79 | 1 | $0 (2022) |
| GENZYME CORPORATION | $83.14 | 1 | $0 (2019) |
| Lilly USA, LLC | $82.30 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22.34 | 1 | Medtronic, Inc. ($22.34) |
| 2023 | $407.09 | 10 | AstraZeneca Pharmaceuticals LP ($146.73) |
| 2022 | $287.97 | 7 | Biohaven Pharmaceutical Holding Company Ltd. ($122.79) |
| 2021 | $271.32 | 9 | AstraZeneca Pharmaceuticals LP ($230.40) |
| 2020 | $27.78 | 2 | Allergan, Inc. ($27.78) |
| 2019 | $207.11 | 3 | Janssen Pharmaceuticals, Inc ($109.52) |
| 2018 | $766.19 | 31 | Janssen Pharmaceuticals, Inc ($251.18) |
| 2017 | $746.17 | 30 | Janssen Pharmaceuticals, Inc ($216.11) |
All Payment Transactions
93 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/04/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $98.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/07/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/07/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: INSOMNIA | ||||||
| 03/23/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.53 | General |
| Category: NEUROSCIENCE | ||||||
| 03/09/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: NEUROSCIENCE | ||||||
| 03/09/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.27 | General |
| Category: NEUROSCIENCE | ||||||
| 03/01/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/08/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.49 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $96.20 | General |
| Category: NEUROSCIENCE | ||||||
| 01/12/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/08/2022 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $92.33 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 06/23/2022 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 06/09/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $122.79 | General |
| Category: PRIMARY CARE | ||||||
| 05/25/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/28/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/03/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/21/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/07/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/04/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/14/2021 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: Neuroscience | ||||||
| 07/22/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/13/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $111.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/18/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/21/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.47 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. Joseph Dryer, DO
Dr. Joseph Dryer, DO is a Internal Medicine healthcare provider based in Oldsmar, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2008. The National Provider Identifier (NPI) number assigned to this provider is 1912167743.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Dryer, DO has received a total of $2,736 in payments from pharmaceutical and medical device companies, with $22.34 received in 2024. These payments were reported across 93 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($2,725).
Ad
Practice Information
- Specialty Internal Medicine
- Location Oldsmar, FL
- Active Since 06/16/2008
- Last Updated 01/25/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1912167743
Products in Payments
- FARXIGA (Drug) $686.17
- INVOKANA (Drug) $306.73
- XARELTO (Drug) $264.06
- Victoza (Drug) $263.71
- VRAYLAR (Drug) $189.66
- INTELLIS ADAPTIVESTIM (Device) $132.93
- QUVIVIQ (Drug) $124.95
- NURTEC ODT (Drug) $122.79
- Synthroid (Drug) $97.08
- THYMOGLOBULIN (Drug) $83.14
- Trintellix (Drug) $76.38
- STEGLATRO (Drug) $75.00
- TRADJENTA (Drug) $68.98
- JANUVIA (Drug) $68.82
- BELSOMRA (Drug) $32.39
- Prolia (Biological) $28.73
- Levemir (Drug) $21.83
- ZOSTAVAX (Biological) $18.72
- UBRELVY (Drug) $16.45
- TRULICITY (Drug) $13.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.